Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.23.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Accounts receivable, allowance for credit loss, current $ 971 $ 911
Total assets [1] $ 2,967,348 $ 2,876,821
Preferred stock, par value (in usd per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Treasury stock (in shares) 2,101,795 2,101,795
Class A Common Stock    
Common stock, par value (in usd per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 36,132,157 36,050,157
Common stock, shares outstanding (in shares) 34,030,362 33,948,362
Class B Common Stock    
Common stock, par value (in usd per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 144,000,000 144,000,000
Common stock, shares issued (in shares) 18,000,000 18,000,000
Common stock, shares outstanding (in shares) 18,000,000 18,000,000
Variable Interest Entity, Primary Beneficiary    
Total assets $ 238,666 $ 213,913
Total liabilities $ 41,821 $ 50,729
[1] Includes restricted assets of consolidated variable interest entities (“VIEs”) at March 31, 2023 and December 31, 2022 of $238,666 and $213,913, respectively. Includes non-recourse liabilities of consolidated VIEs at March 31, 2023 and December 31, 2022 of $41,821 and $50,729, respectively. See Note 13.